Symbols / GAL $50.69 +0.04%
GAL Chart
About
The Adviser primarily invests the assets of the fund among exchange traded products ("ETPs") that provide balanced exposure to domestic and international debt and equity securities. The fund typically allocates approximately 60% of its assets to equity securities, though this percentage can vary based on the Adviser's tactical decisions.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | 3.30% |
| Payout | — | Employees | — | IPO | — |
| P/E | 21.10 | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | 52.00 | 52W Low | 41.00 |
| Beta | — | Avg Volume | 18.75K | Volume | 10.70K |
| Target Price | — | Recom | — | Prev Close | $50.67 |
| Price | $50.69 | Change | 0.04% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest GAL news- How (GAL) Movements Inform Risk Allocation Models - Stock Traders Daily Wed, 25 Feb 2026 00
- GAL.AX stock jumps 32.56% to A$0.285 on ASX: technical breakout may set next leg higher - Meyka Wed, 21 Jan 2026 08
- Experimental Fabry gene therapy lets some patients stop enzyme replacement - Stock Titan Fri, 06 Feb 2026 08
- Trading Systems Reacting to (GAL) Volatility - Stock Traders Daily Fri, 13 Feb 2026 23
- Galantas Gold to Acquire Past-Producing Andacollo Oro Project in Chile - TipRanks ue, 06 Jan 2026 08
- Rare illness spreading across US that causes meat allergy has sparked warning from officials - tyla.com Wed, 27 Aug 2025 07
- Galantas Gold (CVE:GAL) Has Debt But No Earnings; Should You Worry? - simplywall.st Fri, 22 Aug 2025 07
- What Percentage of Americans Own Stock? - Gallup News Mon, 05 May 2025 07
- 45-Gallon Capacity: DR Power's First Commercial-Grade Walk-Behind Vacuum Sets New Cleanup Standard - Stock Titan hu, 18 Sep 2025 07
- Galformer: a transformer with generative decoding and a hybrid loss function for multi-step stock market index prediction - Nature hu, 10 Oct 2024 07
- RNS Hotlist with Zak Mir: RKT, GAL, EDEN, ECR, TEK, GGP, APTA, BIRD, NET, ENSI, TUN, PALM & PRD - Share Talk Wed, 07 Jan 2026 08
- Red meat allergy webinar registration now open - UKNow ue, 22 Apr 2025 07
- Galmed Pharmaceuticals Stock: Will The Momentum Last? - timothysykes.com ue, 06 May 2025 07
- Higher gas prices are likely coming to the pump after oil prices jump in wake of U.S. strikes in Iran - NBC News Mon, 02 Mar 2026 08
- First documented alpha-gal syndrome fatality from mammalian meat reported - Healio Fri, 14 Nov 2025 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for GAL
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|